There are only a few times in life when you get to live through a revolution. For many of us, this is our third: first the internet, then mobile, now AI Superintelligence. In moments of foundational ...

Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...

We are actively working to enhance your experience by translating more content. However, please be aware that the page you are about to visit has not yet been translated. We appreciate your ...